Bio Break: Understanding Clinical Trials – Key Steps and Expert Insights

Resources

Bio Break: Understanding Clinical Trials – Key Steps and Expert Insights

In this engaging episode of Bio Break, Nick and Joris dive into the complexities of clinical trials as a critical component of medical product development. Whether you’re a developer embarking on your first trial or a seasoned professional seeking guidance, this discussion provides actionable insights and resources to streamline the process.

Nick explains the importance of starting with the Clinical Laboratory Standards Institute (CLSI), a trusted resource for comprehensive guidance documents that address every facet of trial design. He highlights CLSI document ACP 1782, which details methodologies for determining the limit of blank, limit of detection, and the essential limit of quantification—crucial factors for validating medical diagnostics.

The conversation also touches on addressing environmental substances that could interfere with trial results. From chewing gum to caffeine, CLSI’s EP7-A2 guidance document offers a framework for evaluating interfering compounds in diagnostics, ensuring reliable data even in challenging conditions. For developers working with saliva-based tests or other sensitive diagnostic tools, these guidelines are indispensable.

Precision and bias are also at the forefront of trial considerations, and Nick mentions EP15-A2, a vital CLSI resource for understanding and accounting for these metrics in trial setups. From power calculations to designing interference panels, the discussion underscores how these documents empower developers to create robust, reproducible studies.

If you’re navigating the intricacies of clinical trials, this episode is your gateway to essential knowledge. Learn how leveraging the right resources can elevate the quality and reliability of your medical device development process.

Understanding Clinical Trials – Key Steps and Expert Insights

YouTube video thumbnail
Cover of the free StarFish Medical guide “Drug Delivery Decisions,” featuring a gradient design with wave patterns, offering insights on drug-device combination product strategy.

This in-depth drug delivery strategy guide from StarFish Medical explores how to design, develop, and deliver breakthrough drug-device combination products.

StarFish Medical Request for Proposal (RFP) template cover with white star logo and DNA helix graphic.

Choosing the right design and development partner is one of the most critical decisions in bringing a medical device to market.

Thumbnail showing “First to Invent” with yellow exclamation marks transitioning via red arrow to “First to File” with a folder of patent documents, illustrating the shift in patent rules discussed in the Bio Break episode.

Nick Allan and Nigel Syrotuck dive into the evolution of patent documentation habits in engineering and medical device development.

Magnified view of printed circuit board inspection during PCBA bring-up for medical device prototype development.

Bringing up a new printed circuit board assembly (PCBA) for a medical device is both exciting and high-stakes.